$0.29
+0.01 (+5.22%)
Open$0.27
Previous Close$0.27
Day High$0.29
Day Low$0.26
52W High$0.50
52W Low$0.24
Volume—
Avg Volume243.8K
Market Cap26.87M
P/E Ratio—
EPS$-0.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
5 analysts
Price Target
+5,364.7% upside
Current
$0.29
$0.29
Target
$15.64
$15.64
$13.90
$15.64 avg
$22.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.64M | 1.12M | 13.95M |
| Net Income | -9,197,916 | -5,630,611 | 2.16M |
| Profit Margin | -560.3% | -532.3% | 15.5% |
| EBITDA | -8,397,668 | -5,426,326 | 3.52M |
| Free Cash Flow | — | — | 2.06M |
| Rev Growth | +47.0% | +47.0% | +17.1% |
| Debt/Equity | 0.02 | 0.02 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |